Povorcitinib Shows Promise for Moderate-to-Severe Hidradenitis Suppurativa

For those living with hidradenitis suppurativa — a condition that carves painful, persistent wounds into daily life — the search for relief has long outpaced the available remedies. Two large clinical trials published in Nature Medicine suggest that povorcitinib, an oral pill that quiets a key inflammatory signal in the body, may meaningfully tip that balance, with roughly twice as many patients achieving significant lesion reduction compared to placebo. The findings arrive as a measured but genuine step forward, tempered by the longer horizon of safety questions that only time and wider use w